Commitments and Contingencies (Detail) - Novo License Agreement - USD ($) $ in Millions |
Dec. 31, 2025 |
Feb. 28, 2007 |
|---|---|---|
| Developmental And Regulatory Milestone Payment | Maximum | Type 1 Diabetes | ||
| Commitments And Contingencies [Line Items] | ||
| Potential milestone payment | $ 6.0 | |
| Developmental And Regulatory Milestone Payment | Maximum | Type 2 Diabetes | ||
| Commitments And Contingencies [Line Items] | ||
| Potential milestone payment | 50.5 | |
| Developmental And Regulatory Milestone Payment | Maximum | Other Indication | ||
| Commitments And Contingencies [Line Items] | ||
| Potential milestone payment | 115.0 | |
| Sales-based Milestones Payment | ||
| Commitments And Contingencies [Line Items] | ||
| Potential milestone payment | $ 75.0 | |
| Satisfaction of Milestone Payment | ||
| Commitments And Contingencies [Line Items] | ||
| Potential milestone payment | $ 1.0 |